Study based on observing the differences in symptomatology between positive and negative children participating in Osona, and what seasonal patterns the virus follows
Pediatricians have found that the coronavirus usually manifests itself in a mild form in children and that the transmitting role of the child is insignificant, especially in the school environment.
However, there have been some cases of complications that, despite being in a very low percentage, can become serious, such as the Pediatric Multisystemic Inflammatory Syndrome associated with COVID-19, which can cause severe inflammation of organs and tissues such as the heart, lungs, blood vessels, gastrointestinal system, among others.
Description of the Study:
- Title: Infecció pel virus SARS-CoV-2 en població pediàtrica d’Osona. Característiques clíniques, epidemiològiques i seroprevalença.
- Principal investigator: Montserrat Ruiz.
- Centers of Implementation: Consorci Hospitalari de Vic, Centres d’Atenció Primària d’Osona (ICS i EBA: Tona, Seva, Santa Eugènia de Berga, Taradell, Manlleu, Vic Nord, Vic Sud, Sant Hipòlit de Voltregà, Lluçanès, Torelló), Clínica Bayés, et al.
- Study Population: 430 cases of children under 15 years of age who have undergone a PCR test.
- Design: Collection of data from participating children who are followed up at six and twelve months after a PCR test to learn how the episode has resolved and if there have been any complications.
Objectives of the Study:
Principal Objective: To identify patterns of symptomatology associated with SARS-CoV-2 virus, incidence and prevalence of cases, seroprevalence and to guide pediatric professionals in detection.
More about this Study:
Added Value: The project was awarded last year with the XXI Osona Research Grant promoted by the Osona delegation of the Col·legi de Metges de Barcelona.
Other Studies about Pediatrics:
What is the role of children in the dynamics of intradomiciliary transmission of SARS-CoV-2? This prospective study confirms that children are less likely to transmit SARS-CoV-2.
Open, randomized, adaptive, phase III clinical trial study to evaluate the efficacy of various pharmacological alternatives in the treatment of severe infection in COVID-19 pediatric patients.
Which is the COVID-19 onset and severity? We study the role of the nasopharyngeal microbiota and the host ACE2 receptor in the pediatric and adult population to have an answer.
This study aims to characterise COVID-19 in the paediatric population by studying clinical, serological, biochemical and immunological variables in these patients.
This study aims to analyse the impact of COVID-19 environmental stressors on emotions and behavior in children and adolescents with ASD.
How do children transmit SARS-CoV-2? This COVID-19 study aims to answer this question by analyzing pediatric age cases in school like environments.
How do host’s genetics influence the susceptibility and severity of the infection? Find out more in GEN-COVID, a COVID-19 study about genetics.
A national register to study how COVID-19 behaves in the pediatric population, its impact on the global epidemic, and its consequences on the child and youth population.
This study allows in-depth understanding of the transmission of the infection, as well as the immune response that occurs in pregnant mothers and the newborn population during COVID-19.